Signaling mechanisms of ROS-mediated nuclear factor kappa-B (NF-κB)... | Download Scientific Diagram
IJMS | Free Full-Text | Targeting NF-κB-Inducing Kinase (NIK) in Immunity, Inflammation, and Cancer | HTML
The Nuclear Factor Kappa B (NF-kB) signaling in cancer development and immune diseases - ScienceDirect
Is NF-κB a good target for cancer therapy? Hopes and pitfalls | Nature Reviews Drug Discovery
Frontiers | MicroRNA Roles in the Nuclear Factor Kappa B Signaling Pathway in Cancer
Genistein as a regulator of signaling pathways and microRNAs in different types of cancers | Cancer Cell International | Full Text
Cancers | Free Full-Text | Context-Dependent Role of NF-κB Signaling in Primary Liver Cancer—from Tumor Development to Therapeutic Implications | HTML
The nuclear factor-kappa B pathway and response to treatment in breast cancer | Pharmacogenomics
Nuclear Factor Kappa B Pathway and human cancer therapeutics
NF-κB, inflammation, immunity and cancer: coming of age | Nature Reviews Immunology
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
![PDF] Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. | Semantic Scholar](https://d3i71xaburhd42.cloudfront.net/7cd42ab9fdbe297f0ef3e83a7a914f34707cc418/2-Figure1-1.png "PDF] Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. | Semantic Scholar")
PDF] Control of oncogenesis and cancer therapy resistance by the transcription factor NF-kappaB. | Semantic Scholar
Regulation of Nuclear Factor-KappaB (NF-κB) signaling pathway by non-coding RNAs in cancer: Inhibiting or promoting carcinogenesis? - ScienceDirect
PDF) Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism | Narayan Mandal - Academia.edu
Frontiers | What Is Nuclear Factor Kappa B (NF-κB) Doing in and to the Mitochondrion?
NF-κB inhibitors in treatment and prevention of lung cancer - ScienceDirect
Cancers | Free Full-Text | NF-κB/Rel Transcription Factors in Pancreatic Cancer: Focusing on RelA, c-Rel, and RelB | HTML
The nuclear factor-kappa B pathway and response to treatment in breast cancer | Pharmacogenomics
NF-κB in the New Era of Cancer Therapy: Trends in Cancer
Frontiers | Targeting Nuclear Factor-Kappa B to Overcome Resistance to Chemotherapy
Chronic inflammation and cancer: potential chemoprevention through nuclear factor kappa B and p53 mutual antagonism – ScienceOpen
Carotenoid derivatives inhibit nuclear factor kappa B activity in bone and cancer cells by targeting key thiol groups - ScienceDirect
Expression Of Intracellular Components of the NF-κB Alternative Pathway (NF-κB2, RelB, NIK and Bcl3) is Associated With Clinical Outcome of NSCLC Patients | Scientific Reports
DNA damage-induced nuclear factor-kappa B activation and its roles in cancer progression
